Investigations of remibrutinib in models pertinent to multiple sclerosis

Key Points

• This research aims to evaluate the effects of remibrutinib on inflammatory outcomes in models related to multiple sclerosis.
• Utilized models pertinent to multiple sclerosis (MS)
• Examined effects on memory B cells in mice
• Awaited Phase 3 clinical trial results
• Remibrutinib favorably affects inflammatory outcomes in MS models
• Specific data on event rates or metrics not reported due to ongoing trials